Gabriel Cohn's Insider Trades & SAST Disclosures

Gabriel Cohn's most recent trade in Q32 Bio Inc. was a trade of 4,290 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 1, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Q32 Bio Inc.
Gabriel Cohn Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 4,290 8,710 - - Restricted Stock Units
Q32 Bio Inc.
Gabriel Cohn Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2022 4,290 4,290 (0%) 0% - Common Stock
Q32 Bio Inc.
Gabriel Cohn Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.78 per share. 01 Jan 2022 1,661 2,629 (0%) 0% 3.8 6,279 Common Stock
Q32 Bio Inc.
Gabriel Cohn Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2021 78,000 78,000 - - Employee Stock Option (Right to Buy)
Q32 Bio Inc.
Gabriel Cohn Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2021 13,000 13,000 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades